Skip to content
Non-Current Liabilities

Unrecognized Tax Benefits - Impacting Effective Tax Rate

Merck & Co. Unrecognized Tax Benefits - Impacting Effective Tax Rate increased by 13.6% to $2.5B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 13.6%, from $2.2B to $2.5B. Over 5 years (FY 2020 to FY 2025), Unrecognized Tax Benefits - Impacting Effective Tax Rate shows an upward trend with a 10.8% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.

Analysis

StatementBalance Sheet Statement
SectionNon-Current Liabilities
CategoryRisk
SignalLower is better
VolatilityStable
First reportedQ4 2015
Last reportedQ4 2025Feb 24, 2026

How to read this metric

A higher value indicates greater potential volatility in the effective tax rate should tax positions be settled unfavorably.

Detailed definition

This subset of unrecognized tax benefits represents positions that, if recognized, would directly affect the company's e...

Peer comparison

Widely reported by large-cap peers to provide transparency into the sensitivity of the effective tax rate to tax audits.

Metric ID: unrecognized_tax_benefits_impacting_etr

Historical Data

5 periods
 Q4 '21Q4 '22Q4 '23Q4 '24Q4 '25
Value$1.5B$1.8B$2.3B$2.2B$2.5B
QoQ Change+20.0%+27.8%-4.3%+13.6%
YoY Change+20.0%+27.8%-4.3%+13.6%
Range$1.5B$2.5B
CAGR+66.7%
Avg YoY Growth+14.3%
Median YoY Growth+16.8%

Unrecognized Tax Benefits - Impacting Effective Tax Rate at Other Companies

Frequently Asked Questions

What is Merck & Co.'s unrecognized tax benefits - impacting effective tax rate?
Merck & Co. (MRK) reported unrecognized tax benefits - impacting effective tax rate of $2.5B in Q4 2025.
How has Merck & Co.'s unrecognized tax benefits - impacting effective tax rate changed year-over-year?
Merck & Co.'s unrecognized tax benefits - impacting effective tax rate increased by 13.6% year-over-year, from $2.2B to $2.5B.
What is the long-term trend for Merck & Co.'s unrecognized tax benefits - impacting effective tax rate?
Over 5 years (2020 to 2025), Merck & Co.'s unrecognized tax benefits - impacting effective tax rate has grown at a 10.8% compound annual growth rate (CAGR), from $1.5B to $2.5B.
What does unrecognized tax benefits - impacting effective tax rate mean?
The portion of uncertain tax benefits that would change the company's reported tax rate if they were finalized.